These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Henry NL; Giles JT; Stearns V Oncology (Williston Park); 2008 Nov; 22(12):1401-8. PubMed ID: 19086600 [TBL] [Abstract][Full Text] [Related]
4. Role of oestrogen in the development of joint symptoms? Tan AL; Emery P Lancet Oncol; 2008 Sep; 9(9):817-8. PubMed ID: 18760239 [No Abstract] [Full Text] [Related]
5. Omega-3 Fatty Acids for Aromatase Inhibitor-Induced Musculoskeletal Pain: Anything Other Than a Placebo Effect? Gianni L; Arcangeli V; Tamburini E; Tassinari D J Clin Oncol; 2015 Dec; 33(36):4311-2. PubMed ID: 26392100 [No Abstract] [Full Text] [Related]
6. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927. Hershman DL; Unger JM; Crew KD; Awad D; Dakhil SR; Gralow J; Greenlee H; Lew DL; Minasian LM; Till C; Wade JL; Meyskens FL; Moinpour CM J Clin Oncol; 2015 Jun; 33(17):1910-7. PubMed ID: 25940724 [TBL] [Abstract][Full Text] [Related]
7. The Power of the Placebo in Symptom Management. Henry NL; Griggs JJ J Clin Oncol; 2015 Jun; 33(17):1870-2. PubMed ID: 25940722 [No Abstract] [Full Text] [Related]
8. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more? Din OS; Dodwell D; Wakefield RJ; Coleman RE Breast Cancer Res Treat; 2010 Apr; 120(3):525-38. PubMed ID: 20157776 [TBL] [Abstract][Full Text] [Related]
9. Reply to L. Gianni et al. Hershman DL; Unger JM J Clin Oncol; 2015 Dec; 33(36):4312. PubMed ID: 26392106 [No Abstract] [Full Text] [Related]
10. Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Gaillard S; Stearns V Breast Cancer Res; 2011 Mar; 13(2):205. PubMed ID: 21457526 [TBL] [Abstract][Full Text] [Related]
12. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors. Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633 [TBL] [Abstract][Full Text] [Related]